Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Executive Session topic
No spam. Unsubscribe anytime.
Board moves to executive session to review proprietary pricing data
Summary
After presenting public, redacted affordability reports, the board announced an executive session to consider proprietary and confidential data collected under chapter 70.405 RCW; public portion was closed and reconvening was scheduled at 11:00.
Before moving to closed session, the presiding officer publicly announced the purpose and legal authority for the executive session, citing the open public meetings statute language that permits confidential review of proprietary data collected under chapter 70.405 RCW. Members confirmed the public portion would close and that they would reconvene the public Teams link at 11:00.
"Consider moving into an executive session to consider proprietary or confidential data collected or analyzed pursuant to chapter 70.405 RCW," the presiding officer read aloud while announcing the closed meeting purpose. Staff made clear that pricing information from manufacturers, PBMs and some payer-supplied inputs are blacked out in the public reports and will be reviewed only in executive session.
Why it matters: The executive session will allow members access to confidential contract and pricing details necessary for an affordability determination, while the public retains access to redacted summaries and therapeutic analyses posted to the website.
